Journals / Gülhane Tıp Dergisi / 2015 / Cilt: 57 - Sayı: 7

Long-term follow-up of patients undergoing permanent pacemaker implantation: GATA exeperience

KALICI PACEMAKER YERLEŞTIRILEN HASTALARIN UZUN DÖNEM TAKIBI

Pages
408–413
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When comparing VVI and DDD pacing, the mortality rate is lower the dualchamber pacing as compared with ventricular pacing are observed principally in the subgroup of patients with sinus-node dysfunction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Permanent pacemaker implantation is an essential in many cardiovascular disorders.
📊
Key Findings & Data:Material and methods: Between January 1994 and December 2013, 240 consecutive patients implanted VVI or DDD pacemakers (PM)s were examined in this retrospective single-centre study.
💡
Conclusion & Impact:When comparing VVI and DDD pacing, the mortality rate is lower the dualchamber pacing as compared with ventricular pacing are observed principally in the subgroup of patients with sinus-node dysfunction.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Permanent pacemaker implantation is an essential in many cardiovascular disorders. In present, one lead pacemaker implantation (especially ventricular) and dual-chamber pacemakers may be used to treat these disorders. Ventricular pacemaker implantation is less expensive, but dual-chamber pacemakers are known to be more physiologic. In that study, we aimed to compare long-term cardiovascular mortality in those patients. Material and methods: Between January 1994 and December 2013, 240 consecutive patients implanted VVI or DDD pacemakers (PM)s were examined in this retrospective single-centre study. Results: A total of 29 patients underwent VVI PM and 211 underwent DDD PM implantation. The median follow-up duration was 44.1 months (21.6-90.3).). Forty one (17.1%) patients died during the follow-up period. Among the 29 patients implanted with a VVI, 13 died during follow-up. In the DDD group, 28 deaths were recorded. The observed annual rates of death from cardiovascular causes were lower in the patients undergoing DDD PM compared to that of the patients undergoing VVI PM (annual rates of death, 1.5 percent with ventricular pacing and 7.3 percent with physiologic pacing, respectively). Conclusion: The implantation of permanent pacemaker decreases the mortality rate. When comparing VVI and DDD pacing, the mortality rate is lower the dualchamber pacing as compared with ventricular pacing are observed principally in the subgroup of patients with sinus-node dysfunction.

Özet

Amaç: Kalıcı pacemakerlar birçok hastalığın tedavisinde hayati öneme sahiptir. Tek odacıklı (özellikle ventriküler) ve çift odacıklı leadlere sahip olmak üzere iki farklı seçenek bu hastalıkların tedavisinde kullanılabilir. Ventriküler pacemakerlar daha ucuzdur, ancak iki odacıklı pacemakerların daha fizyolojik olduğu bilinmektedir. Bu çalışmada hastalarda uzun dönem kardiyovasküler mortaliteyi karşılaştırmayı amaçladık. Gereç ve Yöntemler: Bu tek merkezli retrospektif çalışmada Ocak 1994 ve Aralık 2013 tarihleri arasında VVI ya da DDD pacemaker takılan 240 ardışıl hasta incelendi.Sonuçlar: Toplam 29 hasta VVI ve 211 hasta ise DDD pacemaker implantasyonuna gitti. Ortanca takip süresi 44,1 aydı (21.6-90.3). Takip süresince 41 (%17,1) hasta kaybedildi. VVI pacemaker implante edilen grupta 13 hasta takip sırasında kaybedildi. DDD grubunda ise 28 hasta kaybedildi. DDD pacemaker implante edilen hastalarda VVI pacemaker implante edilenlere gore gözlemlenen kardiyovasküler nedenlere bağlı yıllık ölüm oranları daha azdı (Fizyolojik pace grubunda %7,3'e karşılık ventriküler pace grubunda %1,5). Sonuç: Kalıcı pacemaker implantasyonu sağlıklı yaşam süresini arttırmaktadır. VVI ve DDD pacemaker karşılaştırıldığında DDD pacemakerlardaki hayat süresi artışı daha çok sinus nod disfonksiyonu olan hastalarda gözlemlenmektedir.

🔖

Cite This Article

ALDEMİR, H., DAŞDELEN, S., GÖKTAŞ, E., DALAK, O., KEÇİLİOĞLU, F., NUREFŞAN, F., İÇLİ, T., KILIÇ, S. (2015). Long-term follow-up of patients undergoing permanent pacemaker implantation: GATA exeperience. Gülhane Tıp Dergisi, Cilt: 57 - Sayı: 7, 408–413. https://ajindex.com/articles/207813

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Epstein AE, DiMarco JP, Ellenbogen a, Estes M, Freedman a, Gettes LS, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline. Am Coll Cardiol. American College of Cardiology Foundation; 2008 May 27;51(21):e1--62
  2. Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK, et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. Engl Med. 1998 Apr 16;338(16):1097--104
  3. Castelnuovo E, Stein K, Pitt M, Garside R, Payne E. The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. Heal Technol Assess. 2005 Nov;9(43):iii, xi--xiii, 1--246
  4. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt O-A, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resyn412 Aralık 2015 Gülhane Tıp Derg chronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association. Eur Hear J. 2013 Aug;34(29):2281--329. Linde-Edelstam C, Nordlander R, Pehrsson SK, Ryden L. double-blind study of submaximal exercise tolerance and variation in paced rate in atrial synchronous compared to activity sensor modulated ventricular pacing. Pacing Clin Electrophysiol. 1992 Jun;15(6):905-- 15. Andersen HR, Nielsen JC, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T, et al. Long-term follow-up of patients from randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet. 1997 Oct 25;350(9086):1210--6. Oldroyd KG, Rae AP, Carter R, Wingate C, Cobbe SM. Double blind crossover comparison of the effects of dual chamber pacing (DDD) and ventricular rate adaptive (VVIR) pacing on neuroendocrine variables, exercise performance, and symptoms in complete heart block. Br Hear J. 1991 Apr;65(4):188--93. Brunner M, Olschewski M, Geibel A, Bode C, Zehender M. Long-term survival after pacemaker implantation. Prognostic importance of gender and baseline patient characteristics. Eur Hear J. 2004 Jan;25(1):88--95. Castelnuovo